Cancellations by sponsors

This database shows cancellations of Australian Register of Therapeutic Goods entries requested by sponsors.

Last updated

23 December 2025

Find out more at Information about cancellations requested by the sponsor - regulatory actions.

Filters applied:

2016

Clear all

1129 result(s) found, displaying 51 to 75

Guerbet Australia Pty Ltd - Optistar LE Mulitpack - Unclassified Cancelled under s41GL(d) of the Act

22 December 2016

Cancellation by sponsor

Requested by Guerbet Australia Pty Ltd
Guerbet Australia Pty Ltd Unclassified Cancelled under s41GL(d) of the Act

22 December 2016

Cancellation by sponsor

Requested by Guerbet Australia Pty Ltd
IMMUCYST BCG 6.6 - 19.2 x 100000000 CFU powder for injection vial Cancelled under s30(1)(c)

22 December 2016

Cancellation by sponsor

Requested by Sanofi-Aventis Australia Pty Ltd
Medela Australia Pty Ltd - Trolley, medical devices Cancelled under s41GL(d) of the Act

22 December 2016

Cancellation by sponsor

Requested by Medela Australia Pty Ltd
MERIOSTA zoledronic acid 4 mg/100 mL injection solution vial Cancelled under s30(1)(c)

22 December 2016

Cancellation by sponsor

Requested by Novartis Pharmaceuticals Australia Pty Ltd
MERIOSTA zoledronic acid 4mg/5mL concentrated injection vial Cancelled under s30(1)(c)

22 December 2016

Cancellation by sponsor

Requested by Novartis Pharmaceuticals Australia Pty Ltd
OSTAZOL zoledronic acid 4 mg/100 mL injection solution vial Cancelled under s30(1)(c)

22 December 2016

Cancellation by sponsor

Requested by Novartis Pharmaceuticals Australia Pty Ltd
OSTAZOL zoledronic acid 4mg/5mL concentrated injection vial Cancelled under s30(1)(c)

22 December 2016

Cancellation by sponsor

Requested by Novartis Pharmaceuticals Australia Pty Ltd
SCHERING-PLOUGH TESTOSTERONE testosterone 100mg implant tube Cancelled under s30(1)(c)

22 December 2016

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
SCHERING-PLOUGH TESTOSTERONE testosterone 200mg implant tube Cancelled under s30(1)(c)

22 December 2016

Cancellation by sponsor

Requested by Merck Sharp & Dohme Australia Pty Ltd
TOVANOR BREEZHALER glycopyrronium (as bromide) 50 microgram powder for inhalation (in capsule) blister Cancelled under s30(1)(c)

22 December 2016

Cancellation by sponsor

Requested by Novartis Pharmaceuticals Australia Pty Ltd
XOTERNA BREEZHALER 110/50 indacaterol (as maleate)/ glycopyrronium (as bromide) 110 microgram / 50 microgram powder for inhalation in hard capsule Cancelled under s30(1)(c)

22 December 2016

Cancellation by sponsor

Requested by Novartis Pharmaceuticals Australia Pty Ltd
ZOLEDRONIC SANDOZ zoledronic acid 4 mg/100 mL injection solution vial Cancelled under s30(1)(c)

22 December 2016

Cancellation by sponsor

Requested by Novartis Pharmaceuticals Australia Pty Ltd
ZOLEDRONIC SANDOZ zoledronic acid 4mg/5mL concentrated injection vial Cancelled under s30(1)(c)

22 December 2016

Cancellation by sponsor

Requested by Novartis Pharmaceuticals Australia Pty Ltd
ALBALON RELIEF phenylephrine hydrochloride 1.2mg/mL single dose eye drops solution ampoule Cancelled under s30(1)(c)

21 December 2016

Cancellation by sponsor

Requested by Allergan Australia Pty Ltd
APO-OLMESARTAN HCTZ 20/12.5 olmesartan medoxomil 20 mg & hydrochlorothiazide 12.5 mg tablet blister pack Cancelled under s30(1)(c)

21 December 2016

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-OLMESARTAN HCTZ 40/12.5 olmesartan medoxomil 40 mg & hydrochlorothiazide 12.5 mg tablet blister pack Cancelled under s30(1)(c)

21 December 2016

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-OLMESARTAN HCTZ 40/25 olmesartan medoxomil 40 mg & hydrochlorothiazide 25 mg tablet blister pack Cancelled under s30(1)(c)

21 December 2016

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-Olmesartan olmesartan medoxomil 20mg tablet blisters Cancelled under s30(1)(c)

21 December 2016

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-Olmesartan olmesartan medoxomil 40mg tablet blisters Cancelled under s30(1)(c)

21 December 2016

Cancellation by sponsor

Requested by Apotex Pty Ltd
BETAGAN levobunolol hydrochloride 5mg/mL (0.5%) eye drops bottle Cancelled under s30(1)(c)

21 December 2016

Cancellation by sponsor

Requested by Allergan Australia Pty Ltd
Fresenius Kabi Australia Pty Ltd - Bag, enema Cancelled under s41GL(d) of the Act

21 December 2016

Cancellation by sponsor

Requested by Fresenius Kabi Australia Pty Ltd
OCUFEN flurbiprofen sodium dihydrate 300 microgram/mL eye drops ampoule Cancelled under s30(1)(c)

21 December 2016

Cancellation by sponsor

Requested by Allergan Australia Pty Ltd
PREFRIN LIQUIFILM EYE DROPS phenylephrine hydrochloride 1.2mg/mL bottle (reformulation) Cancelled under s30(1)(c)

21 December 2016

Cancellation by sponsor

Requested by Allergan Australia Pty Ltd
Dentsply (Australia) Pty Ltd - File, endodontic, hand-held Cancelled under s41GL(d) of the Act

20 December 2016

Cancellation by sponsor

Requested by Dentsply (Australia) Pty Ltd

Last updated

23 December 2025

Sub menu

Product regulation

Safety and shortages

Resources and guidance

Business services

Cancellations by sponsors

Filter results

Decision type

Date of effect

Guerbet Australia Pty Ltd - Optistar LE Mulitpack - Unclassified Cancelled under s41GL(d) of the Act

Guerbet Australia Pty Ltd Unclassified Cancelled under s41GL(d) of the Act

IMMUCYST BCG 6.6 - 19.2 x 100000000 CFU powder for injection vial Cancelled under s30(1)(c)

Medela Australia Pty Ltd - Trolley, medical devices Cancelled under s41GL(d) of the Act

MERIOSTA zoledronic acid 4 mg/100 mL injection solution vial Cancelled under s30(1)(c)

MERIOSTA zoledronic acid 4mg/5mL concentrated injection vial Cancelled under s30(1)(c)

OSTAZOL zoledronic acid 4 mg/100 mL injection solution vial Cancelled under s30(1)(c)

OSTAZOL zoledronic acid 4mg/5mL concentrated injection vial Cancelled under s30(1)(c)

SCHERING-PLOUGH TESTOSTERONE testosterone 100mg implant tube Cancelled under s30(1)(c)

SCHERING-PLOUGH TESTOSTERONE testosterone 200mg implant tube Cancelled under s30(1)(c)

TOVANOR BREEZHALER glycopyrronium (as bromide) 50 microgram powder for inhalation (in capsule) blister Cancelled under s30(1)(c)

XOTERNA BREEZHALER 110/50 indacaterol (as maleate)/ glycopyrronium (as bromide) 110 microgram / 50 microgram powder for inhalation in hard capsule Cancelled under s30(1)(c)

ZOLEDRONIC SANDOZ zoledronic acid 4 mg/100 mL injection solution vial Cancelled under s30(1)(c)

ZOLEDRONIC SANDOZ zoledronic acid 4mg/5mL concentrated injection vial Cancelled under s30(1)(c)

ALBALON RELIEF phenylephrine hydrochloride 1.2mg/mL single dose eye drops solution ampoule Cancelled under s30(1)(c)

APO-OLMESARTAN HCTZ 20/12.5 olmesartan medoxomil 20 mg & hydrochlorothiazide 12.5 mg tablet blister pack Cancelled under s30(1)(c)

APO-OLMESARTAN HCTZ 40/12.5 olmesartan medoxomil 40 mg & hydrochlorothiazide 12.5 mg tablet blister pack Cancelled under s30(1)(c)

APO-OLMESARTAN HCTZ 40/25 olmesartan medoxomil 40 mg & hydrochlorothiazide 25 mg tablet blister pack Cancelled under s30(1)(c)

APO-Olmesartan olmesartan medoxomil 20mg tablet blisters Cancelled under s30(1)(c)

APO-Olmesartan olmesartan medoxomil 40mg tablet blisters Cancelled under s30(1)(c)

BETAGAN levobunolol hydrochloride 5mg/mL (0.5%) eye drops bottle Cancelled under s30(1)(c)

Fresenius Kabi Australia Pty Ltd - Bag, enema Cancelled under s41GL(d) of the Act

OCUFEN flurbiprofen sodium dihydrate 300 microgram/mL eye drops ampoule Cancelled under s30(1)(c)

PREFRIN LIQUIFILM EYE DROPS phenylephrine hydrochloride 1.2mg/mL bottle (reformulation) Cancelled under s30(1)(c)

Dentsply (Australia) Pty Ltd - File, endodontic, hand-held Cancelled under s41GL(d) of the Act

Is there anything wrong with this page?